<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Why Moderna (MRNA) Shares Are Falling Today — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Why Moderna (MRNA) Shares Are Falling Today</h2>
    <div class="badge">2025-09-08T18:26:30+00:00</div>
    <ul>
      <li>Moderna is down 42.9% since the beginning of the year, and at $23.99 per share, it is trading 69.8% below its 52-week high of $79.51 from September 2024.</li>
<li>Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 4.8% in the afternoon session after competitors Pfizer and BioNTech announced positive topline results for their updated 2025-2026 COVID-19 vaccine formula.</li>
<li>What Is The Market Telling Us Moderna’s shares are extremely volatile and have had 50 moves greater than 5% over the last year.</li>
<li>The previous big move we wrote about was 12 days ago when the stock gained 3.6% on the news that the company announced it received U.S.</li>
<li>Food and Drug Administration (FDA) approval for its updated COVID-19 vaccines for the 2025-2026 season.</li>
<li>Investors who bought $1,000 worth of Moderna’s shares 5 years ago would now be looking at an investment worth $441.46.</li>
<li>At the conference, CEO Stéphane Bancel outlined strategic priorities but also noted the company faces market uncertainties and is targeting cash flow break-even by 2028.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Why%20Moderna%20%28MRNA%29%20Shares%20Are%20Falling%20Today%0A%E2%80%A2%20Moderna%20is%20down%2042.9%25%20since%20the%20beginning%20of%20the%20year%2C%20and%20at%20%2423.99%20per%20share%2C%20it%20is%20trading%2069.8%25%20below%20its%2052-week%20high%20of%20%2479.51%20from%20September%202024.%0A%E2%80%A2%20Shares%20of%20biotechnology%20company%20Moderna%20%28NASDAQ%3AMRNA%29%20fell%204.8%25%20in%20the%20afternoon%20session%20after%20competitors%20Pfizer%20and%20BioNTech%20announced%20positive%20topline%20results%20for%20their%20updated%202025-2026%20COVID-19%20vaccine%20formula.%0A%E2%80%A2%20What%20Is%20The%20Market%20Telling%20Us%20Moderna%E2%80%99s%20shares%20are%20extremely%20volatile%20and%20have%20had%2050%20moves%20greater%20than%205%25%20over%20the%20last%20year.%0A%E2%80%A2%20The%20previous%20big%20move%20we%20wrote%20about%20was%2012%20days%20ago%20when%20the%20stock%20gained%203.6%25%20on%20the%20news%20that%20the%20company%20announced%20it%20received%20U.S.%0A%E2%80%A2%20Food%20and%20Drug%20Administration%20%28FDA%29%20approval%20for%20its%20updated%20COVID-19%20vaccines%20for%20the%202025-2026%20season.%0A%E2%80%A2%20Investors%20who%20bought%20%241%2C000%20worth%20of%20Moderna%E2%80%99s%20shares%205%20years%20ago%20would%20now%20be%20looking%20at%20an%20investment%20worth%20%24441.46.%0A%E2%80%A2%20At%20the%20conference%2C%20CEO%20St%C3%A9phane%20Bancel%20outlined%20strategic%20priorities%20but%20also%20noted%20the%20company%20faces%20market%20uncertainties%20and%20is%20targeting%20cash%20flow%20break-even%20by%202028.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fwhy-moderna-mrna-shares-are-falling-today%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/why-moderna-mrna-shares-falling-182630851.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>